×
AllNewsImagesMaps Videos Shopping Books
Search tools

ADA25: Lilly's oral GLP-1 dodges side effect minefield that sunk Pfizer drug

FirstWord Pharma
Eli Lilly detailed safety results for its oral GLP-1 asset orforglipron at the American Diabetes Association (ADA) meeting Saturday,...
2 days ago

The 5 Most Interesting Analyst Questions From Pfizer’s Q1 Earnings Call

Yahoo Finance
Pfizer's first quarter results drew a positive market response as management emphasized margin improvement and disciplined expense control,...
1 day ago

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan

CNBC
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of...
6 days ago

FDA expands COVID vaccine warning about heart side effect risk for young males

CBS News
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and...
1 month ago

Advanced colon cancer patients lived twice as long with a Pfizer combo therapy, trial finds

NBC News
A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to late-stage trial data...
3 weeks ago

Why Apple, Microsoft, Pfizer and other U.S. multinational corporations set up shop in Ireland

CNBC
U.S. firms remain attracted to Ireland's strong business environment built on favorable tax treatment of intellectual property.
2 weeks ago

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer

CNBC
Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy...
6 days ago

Pfizer Inc.

Britannica
The first was oxytetracycline, discovered in 1950. This advance shifted Pfizer from a chemical manufacturer to a research-based pharmaceutical...
3 days ago

Pfizer’s Dividend Backed by Strong Free Cash Flow

MSN
Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company's strategy focuses on steadily increasing its dividend,...
5 hours ago

Pfizer Secures Global Licensing Rights Outside China for 3SBio’s Dual-Target Cancer Therapy SSGJ-707

GeneOnline
Pfizer Inc. has announced an exclusive global licensing agreement, excluding China, with 3SBio Inc., a prominent Chinese biopharmaceutical...
2 hours ago